Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Co-delivery of Interferon Regulatory Factor 5 (IRF5) siRNA and dasatinib by a disulfide bond bearing polymeric carrier for enhanced anti-inflammatory effects. | Int J Biol Macromol | 2024 | 39486736 | PubTator, text mining | PubMed |
| Deciphering cell-specific genetic insights: Unraveling the immunogenetic landscape of systemic lupus erythematosus. | Mol Immunol | 2024 | 39476438 | PubTator, text mining | PubMed |
| TBK1 is involved in M-CSF-induced macrophage polarization through mediating the IRF5/IRF4 axis. | FEBS J | 2024 | 39434428 | PubTator, text mining | PubMed |
| Exploring the Role of Secondary Metabolites from Plants and Microbes as Modulators of Macrophage Differentiation. | Cardiovasc Hematol Disord Drug Targets | 2024 | 39400021 | PubTator, text mining | PubMed |
| Role of toll-like receptor 4/mutant myeloid differentiation primary response 88/nuclear factor kappa-B mediated inflammation in diabetes mellitus with Northwest dryness syndrome. | J Tradit Chin Med | 2024 | 39380227 | PubTator, text mining | PubMed |
| Ultrasound-Responsive Nanocarriers Delivering siRNA and Fe3O4 Nanoparticles Reprogram Macrophages and Inhibit M2 Polarization for Enhanced NSCLC Immunotherapy. | ACS Appl Mater Interfaces | 2024 | 39378273 | PubTator, text mining | PubMed |
| IRF5 Variants Are Risk Factors for Systemic Lupus Erythematosus in Two Mexican Populations. | J Clin Rheumatol | 2024 | 39271190 | PubTator, text mining | PubMed |
| Genetic associations with disease in populations with Indigenous American ancestries. | Genet Mol Biol | 2024 | 39254840 | PubTator, text mining | PubMed |
| Transcriptomic response of lumpfish (Cyclopterus lumpus) head kidney to viral mimic, with a focus on the interferon regulatory factor family. | Front Immunol | 2024 | 39211041 | PubTator, text mining | PubMed |
| The primate-specific presence of interferon regulatory factor-5 pseudogene 1. | J Med Virol | 2024 | 39169736 | PubTator, text mining | PubMed |
| A2 reactive astrocyte-derived exosomes alleviate cerebral ischemia-reperfusion injury by delivering miR-628. | J Cell Mol Med | 2024 | 39159174 | PubTator, text mining | PubMed |
| Pathoimmunological analyses of fatal E11 infection in premature infants. | Front Cell Infect Microbiol | 2024 | 39045132 | PubTator, text mining | PubMed |
| Discovery of new myositis genetic associations through leveraging other immune-mediated diseases. | HGG Adv | 2024 | 39044428 | PubTator, text mining | PubMed |
| IRF5 suppresses metastasis through the regulation of tumor-derived extracellular vesicles and pre-metastatic niche formation. | Sci Rep | 2024 | 38969706 | PubTator, text mining | PubMed |
| Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients. | Clin Rheumatol | 2024 | 38963465 | PubTator, text mining | PubMed |
| Daphnetin Ameliorates Neuropathic Pain via Regulation of Microglial Responses and Glycerophospholipid Metabolism in the Spinal Cord. | Pharmaceuticals (Basel) | 2024 | 38931456 | PubTator, text mining | PubMed |
| IN VIVO STUDY OF POTENTIAL MECHANISMS OF MACROPHAGE REPOLARIZATION ON THE BACKGROUND OF TUMOR GROWTH. | Exp Oncol | 2024 | 38852055 | PubTator, text mining | PubMed |
| The upregulation and transcriptional regulatory mechanisms of Extra spindle pole bodies like 1 in bladder cancer: An immunohistochemistry and high-throughput screening Evaluation. | Heliyon | 2024 | 38813236 | PubTator, text mining | PubMed |
| MyD88 Inhibition Attenuates Cerebral Ischemia-reperfusion Injury by Regulating the Inflammatory Response and Reducing Blood-brain Barrier Damage. | Neuroscience | 2024 | 38754722 | PubTator, text mining | PubMed |
| M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C. | Clin Exp Pharmacol Physiol | 2024 | 38745265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=9